Crispr Therapeutics Stock Been: A Roller-Coaster Year Unpacked
CRISPR Therapeutics stock has zigzagged all year, driven by pipeline milestones, regulatory updates, and funding need...
Learn which credit card offers the best rewards for travel to make your journeys even more enjoyable. Explore options now.
26,760 articlesCRISPR Therapeutics stock has zigzagged all year, driven by pipeline milestones, regulatory updates, and funding need...
Walmart is redefining retail competition with a bold mix of groceries, everyday low prices, and omnichannel strength....
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
A CNBC analyst argues that a pivotal policy move on April 9 reshaped the S&P 500’s trajectory, turning volatility int...
As the S&P 500's dividend yield down to a record low challenges income-focused investors, this guide reveals practica...
Scorpio Tankers has moved from a debt-laden balance sheet to net cash of roughly $334 million by early 2026, a develo...
Palantir has a large revenue backlog, a major Army contract on the books, and ambitious growth guidance. This analysi...
As Berkshire Hathaway prepares for a new era, Warren Buffett successor Greg Abel may be quietly orchestrating a bold,...
Intel staged a monster rally, narrowing the gap with AMD. This article breaks down what the surge means for investors...
A veteran mortgage executive leaves loanDepot to launch Trust One Financial, a new broker-focused lender backed by Ea...
Qualcomm is refocusing from smartphones to robotics and AI-ready chips, while its shares trade at a low multiple amid...
iren’s just said words have become a shorthand for the next big hurdle in AI infrastructure: securing reliable power ...